Article Menu
Need Help?
No Article Versions Notes Found
Cite
Owen, C.; Gerrie, A.S.; Banerji, V.; Assouline, S.; Chen, C.; Robinson, K.S.; Lye, E.; Fraser, G. Canadian Evidence-Based Guideline for the First-Line Treatment of Chronic Lymphocytic Leukemia. Curr. Oncol. 2018, 25, 461-474. https://doi.org/10.3747/co.25.4092
Owen C, Gerrie AS, Banerji V, Assouline S, Chen C, Robinson KS, Lye E, Fraser G. Canadian Evidence-Based Guideline for the First-Line Treatment of Chronic Lymphocytic Leukemia. Current Oncology. 2018; 25(5):461-474. https://doi.org/10.3747/co.25.4092
Chicago/Turabian StyleOwen, C., A. S. Gerrie, V. Banerji, S. Assouline, C. Chen, K. S. Robinson, E. Lye, and G. Fraser. 2018. "Canadian Evidence-Based Guideline for the First-Line Treatment of Chronic Lymphocytic Leukemia" Current Oncology 25, no. 5: 461-474. https://doi.org/10.3747/co.25.4092
APA StyleOwen, C., Gerrie, A. S., Banerji, V., Assouline, S., Chen, C., Robinson, K. S., Lye, E., & Fraser, G. (2018). Canadian Evidence-Based Guideline for the First-Line Treatment of Chronic Lymphocytic Leukemia. Current Oncology, 25(5), 461-474. https://doi.org/10.3747/co.25.4092
